Clear Cell Renal Cell Carcinoma - 27 Studies Found

Recruiting : Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma
: Clear Cell Renal Cell Carcinoma
: 2015-10-06
: Drug: Nivolumab 3 mg/kg, IV (in the vein) on day 1 of each 2-week cycle, for a total of 3 doses prior to
Completed : Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA
: Clear Cell Renal Cell Carcinoma
: 2015-11-16
: Drug: G-202 G-202 administered by intravenous infusion on Days 1, 2 and 3 of each 28-day cycle until dis
Recruiting : Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma
: Metastatic Clear Cell Renal Cell Carcinoma
: 2016-05-19
:
  • Drug: Nivolumab Nivolumab IV,

Completed : Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma
: Metastatic Clear Cell Renal Cell Carcinoma
: 2016-07-26
: Drug: Sunitinib
Active, not recruiting : Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)
: Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
: 2012-08-16
:
  • Biological: Nivolumab Other Na
Recruiting : SLM + Axitinib for Clear Cell RCC
: Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
: 2015-08-17
:
  • Drug: Selenomethionine (SLM) S
Recruiting : Addition of X4P-001 to Nivolumab Treatment in Patients With Renal Cell Carcinoma
: Clear Cell Renal Cell Carcinoma
: 2016-09-30
:
  • Drug: X4P-001 Continuous, oral
Not yet recruiting : Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab
:
  • Clear Cell Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
    : 2017-05-04
    :
    • Drug: Nivolumab Nivolumab will
Completed : Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250
: Clear Cell Renal Cell Carcinoma
: 2008-01-03
:
  • Drug: Sorafenib Sorafenib 200

Completed : Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)
:
  • Clear Cell Renal Cell Carcinoma
  • Metastasis

: 2010-02-12
: Drug: Sunitinib 50mg daily(4 weeks on & 2 weeks off), 2 cycles, until progression or unacceptable to
Next >>>